.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Glaucoma Drug Comparison Shows IOP-Lowering Effect

November 1, 2001

Memphis, TN-Travoprost ophthalmic solution (Travatan, Alcon) has been shown to be equal or superior to latanoprost (Xalatan, Pharmacia) and superior to timolol in lowering IOP in patients with open-angle glaucoma or ocular hypertension, according to a recent study.